This report comprises a copy of the following press release:
“Periodic update on transaction details
related to Philips’ share repurchases”, dated
October 29, 2021.
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf, by the undersigned, thereunto duly authorized at
Amsterdam, on October 29, 2021
KONINKLIJKE PHILIPS N.V.
M.J. van Ginneken
(Chief Legal Officer)
October 29, 2021
Periodic update on transaction details related to Philips’ share
Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today
reported that in the period from October 21, 2021 up to and
including October 28, 2021 a total of 2,185,000 of its own common
shares were repurchased, with a weighted average purchase price of
EUR 40.95. These repurchases were made under the repurchase program
for capital reduction purposes, which was announced on July 26,
2021. Since the start of the program, Philips also entered into a
number of forward transactions, with settlement dates in 2022, 2023
and 2024. Further details can be found via this link.
For further information, please
Martijn van der Starre
Philips Global Press Office
Tel.: +31 6 2847 4617
Philips Investor Relations
Tel.: +31 20 597 7055
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology
company focused on improving people's health and well-being, and
enabling better outcomes across the health continuum – from healthy
living and prevention, to diagnosis, treatment and home care.
Philips leverages advanced technology and deep clinical and
consumer insights to deliver integrated solutions. Headquartered in
the Netherlands, the company is a leader in diagnostic imaging,
image-guided therapy, patient monitoring and health informatics, as
well as in consumer health and home care. Philips generated 2020
sales of EUR 17.3 billion and employs approximately 78,000
employees with sales and services in more than 100 countries. News
about Philips can be found at www.philips.com/newscenter.